Skip to main content

Table 2 Hematocrit and extracellular volume (ECV) at different time points: baseline, early after radiation therapy, and follow-up

From: Computed tomography-derived myocardial extracellular volume: an early biomarker of cardiotoxicity in esophageal cancer patients undergoing radiation therapy

 

Baseline

Early after radiation therapy

Follow-up

Hematocrit (%)

39 ± 4

36 ± 4

36 ± 5

ECV (%)

27.9 ± 3.5

30.3 ± 5.4

31.4 ± 4.5

  1. Data are presented as mean ± standard deviation